SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 240 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $73,024,000 | +5321.2% | 635,321 | +7269.5% | 0.74% | +4282.4% |
| Q3 2014 | $1,347,000 | +26.7% | 8,621 | 0.0% | 0.02% | +30.8% |
| Q2 2014 | $1,063,000 | +183.5% | 8,621 | +138.1% | 0.01% | +160.0% |
| Q1 2014 | $375,000 | +15.0% | 3,621 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $326,000 | +34.7% | 3,621 | 0.0% | 0.01% | +66.7% |
| Q3 2013 | $242,000 | -92.0% | 3,621 | -92.1% | 0.00% | -95.0% |
| Q2 2013 | $3,015,000 | – | 45,571 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verition Fund Management LLC | 2,787,800 | $481,760,000 | 55.98% |
| Brenner West Capital Advisors | 1,800,000 | $311,058,000 | 28.01% |
| FNY Managed Accounts LLC | 180,357 | $31,167,493,000 | 25.70% |
| Twin Securities, Inc. | 1,189,192 | $205,505,000 | 24.16% |
| FIRST NEW YORK SECURITIES LLC /NY | 98,099 | $16,952,488,000 | 16.70% |
| HARVEST MANAGEMENT LLC | 77,500 | $13,393,000 | 14.40% |
| Tyrus Capital S.A.M. | 687,800 | $118,859,000 | 13.24% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 472,550 | $81,661,000 | 11.65% |
| ARGENTIERE CAPITAL AG | 151,500 | $26,181,000 | 10.81% |
| Sachem Head Capital | 725,000 | $125,425,000 | 8.31% |